Where Care Excellence Meets Business Success. Transform your operations today - 0333 577 0877
Log in to CareSync Interview Preparation.

Would you like to receive update from CareSync Experts?
Summary, notice description and lot information
The NHS Lincolnshire Integrated Care Board is planning to award a contract under the Provider Selection Regime for Primary Care Enhanced Services, which include phlebotomy, treatment room services, and specialised drug monitoring, among others. The procurement falls under the services category and is classified as general-practitioner services. The procurement method employed is limited, specifying an award procedure without prior publication of a call for competition.
Although the contract is yet to be formally awarded, it signifies an intention to award with a standstill period ending on 12th September 2025. Key decision criteria include quality, value, service integration, and social value, with a contract value estimated at £143,980 for the duration from 1st April 2025 to 31st March 2026, in the UKF3 region. This tender opportunity presents significant growth potential for businesses specialising in health care services, particularly those experienced in general-practitioner operations.
The procurement process is expected to benefit existing providers well-versed in primary care services capable of maintaining high standards across diverse offerings like safeguarding and DVT management. Small to medium-sized enterprises (SMEs), like St Peters Hill Surgery—cited as a potential supplier—are particularly well-positioned to compete, given their ability to deliver integrated, innovative care solutions efficiently under the guidelines of the Health Care Services Regulations 2023.
NHS Lincolnshire ICB is intending to utilise direct award process C of the Provider Selection Regime regulations to award a contract for the provision of: - Primary Care Enhanced Services, including: - Phlebotomy - Treatment Room - Leg Ulcer - Pessaries - Warfarin - DOAC - Gonadorelins (Zoladex) - Specialised Drug Monitoring - Safeguarding - DVT Assessment & Management including D-Dimer Testing The contract duration is from 1st April 2025 to 31st March 2026 and the expected value of the activity for the lifetime of the contract is PS143,980. The provider is an existing provider and the services are existing services.
Notice type, method, and CPV codes
Financial information and value estimates
Contract duration information not available.
Publication, submission, and award timeline
Current status of tender, lots, awards, and contracts
Buyer organisation and contact details
Supplier who was awarded this contract
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact Us